NCCM
ARRY

Nine Chapters Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Nine Chapters Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-99,900
Closed -$456K – 750
2015
Q3 		$456K Buy
+99,900
New +$592K 0.04% 593
2014
Q3 		– Sell
-16,900
Closed -$77K – 1257
2014
Q2 		$77K Sell
16,900
-2,800
-14% -$11.6K 0.01% 891
2014
Q1 		$93K Sell
19,700
-42,600
-68% -$214K 0.01% 766
2013
Q4 		$312K Buy
+62,300
New +$339K 0.03% 597

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Nine Chapters Capital Management's ARRY Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Array Biopharma Inc (ARRY) in Q4 2015, closing a stake of 99,900 shares — an estimated $456K sold.

Nine Chapters Capital Management first reported a position in ARRY in Q4 2013 and held it in 4 quarters. The position peaked at $456K in Q3 2015. 151 funds tracked by Wall St. Rank hold ARRY as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Array Biopharma Inc position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 99,900 Array Biopharma Inc shares in Q4 2015, an estimated $456K.
  • Nine Chapters Capital Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 4 quarters.
  • Nine Chapters Capital Management's Array Biopharma Inc position peaked at $456K in Q3 2015.
  • 151 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.